Healthcare Equipment and Supplies
Company Overview of LED Medical Diagnostics, Inc.
LED Medical Diagnostics Inc. operates as a dental imaging services and technology company in North America. Its products include Velscope Vx system to examine the oral mucosa and screen for tissue abnormalities, including early stage oral cancer and pre-cancer; VELscope Vx Camera kit for fluorescence photography; Vx VELcaps to prevent patient cross contamination; Vx VELsheaths, the single use plastic sheaths that allow proper ventilation for VELscope Vx scope while preventing debris buildup and cross contamination in the operatory; and Vx Value Bundle, a portable handheld device used to conduct oral tissue examinations. The company sells its products to dentists and dental specialists. It ma...
5589 Byrne Road
Burnaby, BC V5J 3J1
Founded in 2003
Key Executives for LED Medical Diagnostics, Inc.
Chief Executive Officer, President and Director
Total Annual Compensation: $50.3K
Director and President of Led Dental Ltd
Total Annual Compensation: $55.0K
Director of Finance
Total Annual Compensation: $46.5K
Compensation as of Fiscal Year 2013.
LED Medical Diagnostics, Inc. Key Developments
LED Medical Diagnostics, Inc. Announces Audited Consolidated Financial Results for the Fourth Quarter and Full Year Ended December 31, 2014; Provides Revenue Guidance for the Year Ending December 31, 2015
Apr 30 15
LED Medical Diagnostics, Inc. announced audited consolidated financial results for the fourth quarter and full year ended December 31, 2014. For the quarter, revenues of $4.6 million, an increase of 2073% from the three months ended December 31, 2013. Net loss was $0.6 million as compared to a net loss of $1.4 million for the three months ended December 31, 2013. EBITDA was negative $0.8 million compared to negative $1.2 million for the three months ended December 31, 2013.
For the year, revenue growth of 256% with total revenue of $9 million as compared to the prior fiscal year. Net loss was $6.1 million as compared to a net loss of $7.0 million for the year ended December 31, 2013. EBITDA was negative $4.9 million, as compared to negative $2.1 million for the year ended December 31, 2013.
The company expects continued strong revenue growth in fiscal year ending December 31, 2015 with revenue guidance of $15 million to $16 million.
LED Dental Inc. Partners with London Drugs to Provide Its Velscope(R) Vx Enhanced Oral Assessment Systems
Apr 16 15
LED Dental Inc. is partnering with London Drugs to provide its VELscope(R) Vx Enhanced Oral Assessment Systems for a pilot program for oral cancer screenings. The pilot program will be conducted by dental professionals on April 14th, April 15th and April 17th at twelve London Drug pharmacies in the lower mainland of B.C. Canada and has been endorsed by the BC Oral Cancer Prevention Program (BC OCPP) and developed with oral medicine and pathology specialist Dr. Samson Ng of UBC.
LED Medical Diagnostics, Inc. Announces Preliminary Sales Results for the Fiscal Year Ended December 31, 2014; Provides Revenue Guidance for the Year Ending December 31, 2015
Jan 21 15
LED Medical Diagnostics Inc. announced preliminary sales results for the fiscal year ended December 31, 2014. The company announced preliminary sales and revenue numbers for the fiscal year ended December 31, 2014 in $9.7 million and $8.5 million, respectively. The company experienced customer orders totaling approximately $9.7 million during fiscal 2014 but was not able to install all sales orders prior to year end resulting in approximately $1.2 million of backlog anticipated to be delivered and recognized as revenue in early fiscal 2015.
The company is providing guidance for the full fiscal year ending December 31, 2015. The company expects revenue to be in the range of $15 Million to $16 Million.
Similar Private Companies By Industry
Recent Private Companies Transactions
January 27, 2015